Park Place Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Park Place Capital's AMGN Position: Q2 2026 in Review
Park Place Capital reduced its Amgen (AMGN) stake by 11% in Q2 2026, selling an estimated $50K and leaving 1,208 shares worth $438K. The position accounts for 0.07% of the portfolio, ranked #163.
Park Place Capital first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.87M in Q3 2023. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Park Place Capital held 1,208 shares of Amgen worth $438K as of Q2 2026.
- Park Place Capital sold 146 Amgen shares in Q2 2026, an estimated $50K.
- Amgen made up 0.07% of Park Place Capital's portfolio in Q2 2026, its #163 holding.
- Park Place Capital first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
- Park Place Capital's Amgen position peaked at $1.87M in Q3 2023.
- 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.